Targeting SARS-CoV-2 papain-like protease in the postvaccine era
Author:
Funder
Canadian Institutes of Health Research
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference76 articles.
1. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach;Naqvi;Biochim. Biophys. Acta Mol. basis Dis.,2020
2. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach;Aftab;J. Transl. Med.,2020
3. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors;Jin;Nature,2020
4. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease;Dai;Science,2020
5. Editorial: Current status of oral antiviral drug treatments for SARS-CoV-2 infection in non-hospitalized patients;Parums;Med. Sci. Monit.,2022
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11
2. Molecular Investigations of Novel Pyrano[2,3-c]Pyrazole Congeners as Potential HCoV-229E Inhibitors: synthesis, Molecular Modeling, 3D QSAR, and ADMET Screening;Polycyclic Aromatic Compounds;2024-09-11
3. Computational modeling and inhibition of SARS-COV-2 Papain-like protease enzyme: A potential therapeutic approach for COVID-19;Journal of Biosafety and Biosecurity;2024-09
4. In-cell bioluminescence resonance energy transfer (BRET)-based assay uncovers ceritinib and CA-074 as SARS-CoV-2 papain-like protease inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-08-20
5. Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape;Nature Communications;2024-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3